S-1治疗化疗难治性胸腺癌。 - Suppr

Suppr

超能文献

S-1 treatment for chemorefractory thymic carcinoma.

作者信息

Ono Akira, Naito Tateaki, Yamamoto Nobuyuki

出版信息

J Thorac Oncol. 2008 Sep;3(9):1076. doi: 10.1097/JTO.0b013e318183af9c.

DOI:10.1097/JTO.0b013e318183af9c

PMID:18758317

Abstract

摘要

相似文献

S-1 treatment for chemorefractory thymic carcinoma.S-1治疗化疗难治性胸腺癌。

J Thorac Oncol. 2008 Sep;3(9):1076. doi: 10.1097/JTO.0b013e318183af9c.

Successful S-1 monotherapy for chemorefractory thymic carcinoma.成功运用S-1单药治疗化疗难治性胸腺癌。

Anticancer Res. 2011 Jan;31(1):299-301.

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.S-1给药对化疗难治性晚期胸腺癌的显著反应。

Chemotherapy. 2014;60(5-6):356-9. doi: 10.1159/000437289. Epub 2015 Sep 22.

S-1 is an active anticancer agent for advanced thymic carcinoma.S-1 是一种用于晚期胸腺癌的活性抗癌药物。

Lung Cancer. 2010 Dec;70(3):357-63. doi: 10.1016/j.lungcan.2010.09.004. Epub 2010 Oct 15.

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.S-1治疗难治性胸腺癌的疗效与生物标志物表达之间的相关性

BMC Cancer. 2016 Feb 25;16:156. doi: 10.1186/s12885-016-2159-7.

[A case of hepatocellular carcinoma treated with TS-1].[一例用替吉奥（TS-1）治疗的肝细胞癌病例]

Nihon Shokakibyo Gakkai Zasshi. 2003 Sep;100(9):1123-8.

[A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].[1例长期应用S-1有效治疗的复发性胸腺癌病例]

Gan To Kagaku Ryoho. 2017 Mar;44(3):239-242.

[A case of pulmonary pleomorphic carcinoma treated with S-1 following radiotherapy].1例放疗后接受S-1治疗的肺多形性癌

Gan To Kagaku Ryoho. 2012 Apr;39(4):687-9.

Multicenter phase II trial of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.多中心 II 期临床试验：S-1 治疗细胞因子难治性转移性肾细胞癌患者。

J Clin Oncol. 2010 Dec 1;28(34):5022-9. doi: 10.1200/JCO.2010.29.1203. Epub 2010 Oct 25.

S-1 induced a durable response in metastatic extramammary Paget's disease.S-1在转移性乳腺外佩吉特病中诱导了持久反应。

J Dermatol. 2013 Aug;40(8):664-5. doi: 10.1111/1346-8138.12177. Epub 2013 May 20.

引用本文的文献

Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study.S-1 联合顺铂同期放化疗治疗局部晚期胸腺癌的 II 期研究：LOGIK1605/JART-1501 研究结果。

Thorac Cancer. 2022 Sep;13(17):2499-2506. doi: 10.1111/1759-7714.14586. Epub 2022 Jul 22.

Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma.既往接受过治疗的胸腺癌患者的挽救性化疗

Cancers (Basel). 2021 Oct 29;13(21):5441. doi: 10.3390/cancers13215441.

Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma.胸腺癌化疗与药物治疗的未来展望

Cancers (Basel). 2021 Oct 19;13(20):5239. doi: 10.3390/cancers13205239.

S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501.S-1 联合顺铂同期放化疗治疗局部晚期胸腺癌：LOGIK1605/JART-1501 研究方案。

Thorac Cancer. 2020 Mar;11(3):693-696. doi: 10.1111/1759-7714.13319. Epub 2020 Feb 5.

S-1 salvage chemotherapy for stage IV thymic carcinoma: a study of 44 cases.IV期胸腺癌的S-1挽救性化疗：44例研究

J Thorac Dis. 2019 Jul;11(7):2816-2821. doi: 10.21037/jtd.2019.06.65.

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.S-1治疗难治性胸腺癌的疗效与生物标志物表达之间的相关性

BMC Cancer. 2016 Feb 25;16:156. doi: 10.1186/s12885-016-2159-7.

The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review.S-1 治疗胸腺癌患者的长期生存：病例报告及文献复习。

Onco Targets Ther. 2013 Dec 27;7:87-90. doi: 10.2147/OTT.S54843. eCollection 2013.

Successful chemotherapy with Carboplatin and s-1 for thymic carcinoma: a case report.卡铂和S-1联合化疗成功治疗胸腺癌：一例报告

Case Rep Oncol. 2013 Oct 24;6(3):526-30. doi: 10.1159/000356143. eCollection 2013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验